SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Dynavax DVAX
An SI Board Since August 2004
Posts SubjectMarks Bans Symbol
184 23 0 DVAX
Emcee:  keokalani'nui Type:  Moderated
Introduction Market Data Compact
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
9Significant confirmation of toll-like receptor technology? That was my initial rBulbaMan-12/19/2005
8Dynavax's HEPLISAV(TM) Hepatitis B Vaccine Shows Statistically Significant Escaram(o)uche-12/19/2005
7No longer follow dvax as an investment, but kinda sorta read the PRs. DVAX'keokalani'nui-8/10/2005
6COley Pharma IPO!! Does anyone follow DVAX anymore? It's kinda quiet here...Luke-8/10/2005
5CSO sold 30k shares, one-half of his position. Venture shareholder sold about 2keokalani'nui-11/30/2004
4I suppose the muted response is due to the highlighted remarks. <i>Dynavakeokalani'nui-11/1/2004
3Blood. 2004 Sep 9 [Epub ahead of print] Related Articles, Links Combination keokalani'nui-9/20/2004
2The recent asthma results landed with a thud, what with no significant clinical keokalani'nui-9/2/2004
1Nice Review of Hep B strategies, thanks to Tuck: Message 20371454keokalani'nui-8/3/2004
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News